140
Views
3
CrossRef citations to date
0
Altmetric
Review

Improving patient safety in transfusion medicine: contemporary challenges and the roles for bedside and laboratory biovigilance in addressing them

, , &
Pages 45-57 | Published online: 10 Jul 2014

References

  • Maluf NS. History of blood transfusion. J Hist Med Allied Sci. 1954;9(1):59–107.
  • Haeger K. . Medicine becomes a science. In: Haeger K, editor. The Illustrated History of Surgery. New York: Bell; 1988:117–141.
  • Greenwalt TJ. A short history of transfusion medicine. Transfusion. 1997;37(5):550–563.
  • Bernheim BM. Blood Transfusion Hemorrhage and the Anemias. Philadelphia: Lippincott; 1917.
  • Tucker H. Blood Work: A Tale of Medicine and Murder in the Scientific Revolution. New York: WW Norton; 2011.
  • Schmidt PJ. The plasma wars: a history. Transfusion. 2012;52 Suppl 1:2S–4S.
  • Mintz PD. . Quality assessment and improvement of blood transfusion practices. In: Mintz PD, editor. Transfusion Therapy: Clinical Principles and Practices. 3rd ed. Bethesda (MD): AABB; 2011:813–836.
  • Hess JR, Smit Sibinga CT, Mintz PD. . History of quality management in transfusion medicine. In: Smit Sibinga CT, editor. Quality Management in Transfusion Medicine. New York: Nova Biomedical; 2013:1–34.
  • Whitby L. Transfusion in war and peace. Lancet. 1945;245(6332):1–4.
  • Hedley-Whyte J, Milamed DR. Blood and war. Ulster Med J. 2010;79(3):125–134.
  • Epstein J, Jaffe HW, Alter HJ, Klein HG. Blood system changes since recognition of transfusion-associated AIDS. Transfusion. 2013;53(10 Pt 2):2365–2374.
  • Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009;49 Suppl 2:1S–29S.
  • Galel SA. Infectious disease screening. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, editorss. Technical Manual. 17th ed. Bethesda: AABB; 2011:239–270.
  • Rothman B, Leonard JC, Vigoda MM. Future of electronic health records: implications for decision support. Mt Sinai J Med. 2012;79(6):757–768.
  • Sharma G, Parwani AV, Raval JS, Triulzi DJ, Benjamin RJ, Pantanowitz L. Contemporary issues in transfusion medicine informatics. J Pathol Inform. 2011;2:3.
  • Bolton-Maggs PHB, Cohen H. Serious hazards of transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol. 2013;163(3):303–314.
  • Skeate RC. Transfusion medicine data as product. Transfusion. 2013;53(6):1153–1156.
  • Whitby LE. The hazards of transfusion. The Lancet. 1942;239(6194):581–585.
  • Scott RB. Complications of blood transfusion (section III). In: Keyes G, Brewer HF, editors. Blood Transfusion. Baltimore: Williams and Wilkins; 1949:133–210.
  • Anstall HB, Blaylock RC, Craven CM. Managing Hazards in the Transfusion Service. Chicago: ASCP; 1993.
  • Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion. 2012;52 Suppl 1:65S–79S.
  • Nance ST, editor. Blood Supply: Risks, Perceptions and Prospects for the Future. Bethesda (MD): American Association of Blood Banks; 1994.
  • Mazzei CA, Popovsky MA, Kopko PM. Noninfectious complications of blood transfusions. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, editors. Technical Manual. 17th ed. Bethesda (MD): AABB; 2011:727–762.
  • Petrides M, AuBuchon JP. To transfuse or not to transfuse: an assessment of risks and benefits. In: Mintz PD, editor. Transfusion Therapy: Clinical Principles and Practice. 3rd ed. Bethesda (MD): AABB; 2011:855–899.
  • Andrzejewski C Jr, McGirr J. . Nursing hemotherapy bedside biovigilance in the recognition and management of suspected transfusion reactions. In: Popovsky MA, editor. Transfusion Reactions. 4th ed. Bethesda (MD): AABB; 2012:551–577.
  • Murphy MF, Saxena S, Smit Sibinga CT. . Patient safety and quality management at the clinical interface. In: Smit Sibinga CT, editor. Quality Management in Transfusion Medicine. New York: Nova Biomedical; 2013:283–314.
  • Taylor C. Clinical activities: medical decision-making, sampling, ordering components, administration, and patient monitoring. In: De Vries RR, Faber JC, editors. Hemovigilance: An Effective Tool for Improving Transfusion Safety. Chichester, UK: Wiley-Blackwell; 2012:126–143.
  • Oldham J, Sinclair L, Hendry C. Right patient, right blood, right care: safe transfusion practice. Br J Nurs. 2009;18(5):312, 314, 316–320.
  • Burns C. The 8 rights of transfusion administration. 2012. Available from: http://thebloodytruth.com/the-8-rights-of-transfusion-administration. Accessed December 31, 2013.
  • Heddle NM, Webert KE. . Febrile nonhemolytic transfusion reactions. In: Popovsky MA, editor. Transfusion Reactions. 4th ed. Bethesda (MD): AABB; 2012:53–97.
  • Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: an analysis of 10 years’ experience. Transfusion. 2000;40(10):1207–1213.
  • Luban NL. Transfusion safety: where are we today? Ann N Y Acad Sci. 2005;1054:325–341.
  • Grimm E, Friedberg RC, Wilkinson DS, AuBuchon JP, Souers RJ, Lehman CM. Blood bank safety practices – a Q-Probes analysis of 122 clinical laboratories. Arch Pathol Lab Med. 2010;134(8):1108–1115.
  • Lumadue JA, Boyd JS, Ness PM. Adherence to a strict specimen-labeling policy decreases the incidence of erroneous blood grouping of blood bank specimens. Transfusion. 1997;37(11–12):1169–1172.
  • Dzik WH, Murphy MF, Andreu G, et al. An international study of the performance of sample collection from patients. Vox Sang. 2003;85(1):40–47.
  • Stubbs JR, Bundy KL, van Buskirk CN. . Preventing transfusion reactions. In: Popovsky MA, editor. Transfusion Reactions. 4th ed. Bethesda (MD): AABB; 2012:597–647.
  • Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409–417.
  • Yaffee DW, Smith DE 3rd, Ursomanno PA, et al. Management of blood transfusion in aortic valve surgery: impact of a blood conservation strategy. Ann Thorac Surg. 2014;97(1):95–101.
  • Carson JL, Charles PA, Herbert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.
  • Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157(1):49–58.
  • Society for the Advancement of Blood Management 2013. Available from: http://www.sabm.org/sites/www.sabm.org/files/SABM-Matrix.pdf. Accessed December 22, 2013.
  • Hohmuth B, Ozawa S, Ashton M, Melseth RL. Patient-centered blood management. J Hosp Med. 2014;9(1):60–65.
  • Seeber P, Shander A. Basics of Blood Management. 2nd ed. Chichester: Wiley-Blackwell; 2013.
  • Kumar A, Figueroa PI, Gowans KL, et al. An evolution in blood management: past, present, and future. Qual Manag Health Care. 2011;20(4):311–321.
  • Ozawa S. Patient blood management: use of topical hemostatic and sealant agents. AORN J. 2013;98(5):461–478.
  • Kumar A, Auron M, Ereth M. Blood management. Anesthesiol Clin. 2013;31(2):433–450.
  • Waters JH. Patient blood management. In: Roback JD, Grossman BJ, Harris T, Hillyer CD, editors. Technical Manual. 17th ed. Bethesda (MD): AABB; 2011:671–685.
  • Kapadia BH, Banerjee S, Issa K, McElroy MJ, Harwin SF, Mont MA. Preoperative blood management strategies for total knee arthroplasty. J Knee Surg. 2013;26(6):373–378.
  • Lin DM, Lin ES, Tran M. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfus Med Rev. 2013;27(4):221–234.
  • Banerjee S, Kapadia BH, Issa K, et al. Postoperative blood loss prevention in total knee arthroplasty. J Knee Surg. 2013;26(6):395–400.
  • Waters JH. Intraoperative blood recovery. ASAIO J. 2013;59(1):11–17.
  • CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet. 2010;376(9734):23–32.
  • Bolliger D, Tanaka KA. Roles of thromboelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev. 2013;27(4):213–220.
  • Yeh SP, Chang CW, Chen JC, et al. A well-designed online transfusion reaction reporting system improves the estimation of transfusion reaction incidence and quality of care in transfusion practice. Am J Clin Pathol. 2011;136(6):842–847.
  • Siegenthaler MA, Schneider P, Vu DH, Tissot JD. Haemovigilance in a general university hospital: need for a more comprehensive classification and codification of transfusion-related events. Vox Sang. 2005;88(1):22–30.
  • Thomas J, Baffa A, Nienhaus, Hannon T. Underrecognition and underreporting of the pulmonary complications to transfusion. Transfusion. 2012;52 Suppl:8A.
  • Mollison PL, Engelfriet CP, Contreras M, editors. Blood Transfusion in Clinical Medicine. 8th ed. Oxford: Blackwell Scientific; 1987;116.
  • Bux J, Sachs UJH. Pulmonary transfusion reactions. Transfus Med Hemother. 2008;35(15):337–345.
  • Andrzejewski C Jr, Popovsky MA. Transfusion-associated adverse pulmonary sequelae: widening our perspective. Transfusion. 2005;45(7):1048–1050.
  • Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774–1789.
  • Shaz BH, Stowell SR, Hillyer CD. Transfusion-related acute lung injury: from bedside to bench and back. Blood. 2011;117(5):1463–1471.
  • Makar RS, Powers A, Stowell CP. Reducing transfusion-related acute lung injury risk: evidence for and approaches to transfusion – related acute lung injury mitigation. Transfus Med Rev. 2012;26(4):305–320.
  • Popovsky MA, Taswell HF. Circulatory overload: an underdiagnosed consequence of transfusion. Transfusion. 1985;25:469.
  • Food and Drug Administration. Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2010. Rockville (MD): CBER Office of Communication, Outreach, and Development; 2011. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM254860.pdf. Accessed February 28, 2012.
  • Magee G, Zbrozek A. Fluid overload is associated with increases in length of stay and hospital costs: pooled analysis of data from more than 600 US hospitals. Clinicoecon Outcomes Res. 2013;5:289–296.
  • Popovsky MA, Audet AM, Andrzejewski C Jr. Transfusion-associated circulatory overload in orthopedic surgery patients: a multi-institutional study. Immunohematology. 1996;12(2):87–89.
  • Robillard P, Nawej K, Chapdelaine A. Transfusion-associated circulatory overload (TACO): current leading cause of transfusion associated fatalities reported to the Quebec Hemovigilance System. Transfus Med. 2009;19:280–281.
  • Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after plasma transfusion. Transfusion. 2012;52(1):160–165.
  • Levy R, Pantanowitz L, Cloutier D, et al. Development of electronic record charting for hospital based transfusion and apheresis medicine services: early adoption perspectives. J Pathol Inform. 2010;1:8.
  • Andrzejewski C Jr, Popovsky MA, Stec TC, et al. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion associated circulatory overload have proinflammatory aspects? Transfusion. 2012;52(11):2310–2320.
  • Andrzejewski C Jr, Casey MA, Popovsky MA. How we view and approach transfusion-associated circulatory overload: pathogenesis, diagnosis, management, mitigation and prevention. Transfusion. 2013;53(12):3037–3047.
  • Finlay HE, Cassorla L, Feiner J, Toy P. Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Pathol. 2005;124(4):601–609.
  • Clifford L, Singh A, Wilson GA, et al. Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications. Transfusion. 2013;53(6):1205–1216.
  • Murphy EL, Kwaan N, Looney MR, et al. Risk factors and outcomes in transfusion-associated circulatory overload. Am J Med. 2013;126(4):357. e29–e38.
  • Lieberman L, Maskens C, Cserti-Gazdewich C, et al. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Transfus Med Rev. 2013;27(4):206–212.
  • Donald T. EMR adoption brings benefits to transfusion medicine. AABB News. 2013;(10):12–17.
  • Murphy MF, Fraser E, Miles D, et al. How do we monitor hospital transfusion practice using an end-to-end electronic transfusion management system? Transfusion. 2012;52(12):2502–2512.
  • Yazer MH, Walters JH. How do I implement a hospital-based blood management program? Transfusion. 2012;52(8):1640–1645.
  • Collins RA, Triulzi D, Waters JH, Reddy V, Yazer MH. Evaluation of real-time clinical decision support systems for platelet and cryoprecipitate orders. Am J Clin Path. 2014;141(1):78–84.
  • Carson TH. Organization. In: American Association of Blood Banks, editor. Standards for Blood Banks and Transfusion Services. 28th ed. Bethesda (MD): AABB; 2012:1–2.
  • Carson TH. Deviations, nonconformances, and adverse events. In: American Association of Blood Banks, editor. Standards for Blood Banks and Transfusion Services. 28th ed. Bethesda (MD): AABB; 2012:79–83.
  • Beigel D. The healthcare system’s perfect storm: the clinical laboratory community faces changes and strategic challenges. Available from: http://laboratory-manager.advanceweb.com/Web-Extras/Online-Extras/The-Healthcare-Systems-Perfect-Storm.aspx. Accessed December 26, 2013.